MAPK3 and neoplasm: Loss of WNK2 expression leads to the activation of oncogenic signaling pathways, such as ERK1/2, JNK-MMP2/9 and Rac1, thus enhancing tumor growth and metastasis [15, 18, 85, 86, 105, 110].